Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) Debt to Equity (2020 - 2025)

Bioventus (BVS) has disclosed Debt to Equity for 6 consecutive years, with $1.22 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity fell 46.18% year-over-year to $1.22, compared with a TTM value of $1.22 through Dec 2025, down 46.18%, and an annual FY2025 reading of $1.22, down 46.18% over the prior year.
  • Debt to Equity was $1.22 for Q4 2025 at Bioventus, down from $1.94 in the prior quarter.
  • Across five years, Debt to Equity topped out at $2.27 in Q4 2024 and bottomed at $0.59 in Q4 2021.
  • Average Debt to Equity over 5 years is $1.4, with a median of $1.65 recorded in 2023.
  • The sharpest move saw Debt to Equity crashed 54.95% in 2021, then surged 198.86% in 2023.
  • Year by year, Debt to Equity stood at $0.59 in 2021, then soared by 72.3% to $1.01 in 2022, then surged by 63.65% to $1.66 in 2023, then skyrocketed by 36.69% to $2.27 in 2024, then tumbled by 46.18% to $1.22 in 2025.
  • Business Quant data shows Debt to Equity for BVS at $1.22 in Q4 2025, $1.94 in Q3 2025, and $1.48 in Q2 2025.